Background {#Sec1}
==========

Nowadays, demand for antibiotic-reduced or antibiotic-free farm animals is rising globally. Its achievement can only be accomplished through a combination of strategies, which include husbandry, biosecurity and alternatives to antibiotics \[[@CR1], [@CR2]\]. The swine industry is foremost in antimicrobial consumption \[[@CR3]\]. Consequently, pig enteric pathogens frequently harbour antimicrobial resistance to a large number of compounds. As there is a requirement to reduce the use of antibiotics, other compounds with antimicrobial activity could be considered to replace them within control strategies. In this context, the use of plant extracts or phytobiotics and organic acids have gained renewed interest because of their potential antimicrobial activity \[[@CR1], [@CR4]--[@CR7]\]. These compounds can be used as feed additives, potentially conferring benefits to health and growth to the host due to their antimicrobial activity and immune response enhancement \[[@CR4], [@CR8]\].

Essential oils (EOs) are volatile lipophilic compounds constituted of a complex mixture of terpenoids and phenols \[[@CR9], [@CR10]\] and are one of the most interesting groups of phytobiotic compounds \[[@CR11], [@CR12]\]. Their antibacterial activity seems to be associated with the disruption of the structure and function of bacteria cell membranes due to their hydrophobicity \[[@CR12]\]. Organic acids have also antimicrobial properties based on their ability to cross the cell membrane, due to the lipophilic nature of their undissociated form, modifying the proton and associated anion concentrations in the cytoplasm \[[@CR13]\]. Consequently, purine bases and essential enzymes are negatively affected and bacterial viability decreases \[[@CR14]\]. These acids are generally available as calcium, potassium or sodium salts to decrease odour and volatility and facilitate the manufacturing processes \[[@CR15]\]. Despite their well-known antimicrobial properties, field results are not always succesful \[[@CR16]--[@CR18]\]. These results demonstrate that further research is needed in order to optimise concentrations, combinations and interactions of these compounds against target pathogens. This information would be considered of value to increase the accuracy of treatments with EOs and/or organic acids.

The present study evaluates the antimicrobial activity of six organic acids and six EOs against *E. coli*, *C. perfringens* and *Salmonella* spp. Interactions between the compounds with greater activity against each bacterial species were also investigated.

Methods {#Sec2}
=======

Bacterial strains and growth conditions {#Sec3}
---------------------------------------

The eighteen strains used in this study belonged to the collection of the Infectious Diseases Unit (IDUC) at the Veterinary Faculty of the University of León. The collection included strains from the Spanish Type Culture Collection (CECT) and field isolates recovered from faecal samples from diarrhoea outbreaks on Spanish swine farms. Table [1](#Tab1){ref-type="table"} summarises the main characteristics of strains used, including virotype for *E. coli*, serotype for *Salmonella* spp. and toxigenic type for *C. perfringens*. In addition, the antimicrobial resistance profile of each strain was determined by disc diffusion test, using breakpoint values provided by Clinical and Laboratory Standard Institute \[[@CR19]\] and the Comité de l'Antibiogramme de la Société Française de Microbiologie. Table 1Main characteristics of bacterial strains used*Escherichia coli*VirotypeAntibiotic resistance profileEC 60 ^a^STbCEF, LINEC 61 ^a^STbLINEC 67 ^a^F18, STa, STb, EAST1LIN, ENR, SULEC 96 ^a^STbAML, CEF, LIN, SULEC 107 ^a^--AML, CEF, LIN, SUL, DOXEC 115 ^a^F18, EAST1AML, LIN, SUL*Salmonella* spp.Serotype/PhagotypeAntibiotic resistance profileSP 11 ^a^Typhimurium/DT 104AML, SPC, LIN, SUL, FFCSP 28 ^a^LondonLIN, SULCECT 443TyphimuriumLINCECT 700InfantisAML, CEF, LIN, SUL, DOXCECT 915CholeraesuisLINCECT 4300EnteriditisLIN, SUL*Clostridium perfringens*Toxigenic typeAntibiotic resistance profileCP 3 ^a^Type A (alpha toxin)CEF, LIN, ENR, SULCP 34 ^a^Type A (alpha toxin)SULCP 52 ^a^Type A (alpha toxin)LIN, ENR, SULCP 89 ^a^Type A (alpha toxin)Not detectedCP 99 ^a^Type A (alpha toxin)LIN, SULCP H ^a^Type A (alpha toxin)SUL*AML* amoxicillina, *SPC* spectinomycin, *ENR* enrofloxacin, *SUL* sulphanomides, *DOX* doxycycline, *CEF* cephalotin, *LIN* lincomycin, *FFC* florfenicol^a ^Field isolates recovered from faecal samples collected from swine farms in Spain

Frozen cultures stored at − 80 °C were revived by inoculation onto appropriate agar plates, tryptic soy agar (TSA) (Scharlab, Spain) for *E. coli* and *Salmonella* spp. and fastidious anaerobe agar (FAA) (Neogen, United Kingdom) for *C. perfringens. E. coli* and *Salmonella* isolates were incubated at 37 °C for 24 h under aerobic conditions while *C. perfringens* were grown at 38.5 °C for 24 to 36 h in an anaerobic workstation with an oxygen-free anaerobic gas mixture (80% N~2,~ 10% H~2~ and 10% CO~2~). Subsequently, the purity of the cultures was confirmed for each strain by examination of colony morphology and Gram staining.

Organic acids and essential oils {#Sec4}
--------------------------------

The products evaluated in this study were provided by Norel SA (Spain). They included six organic acids: formic acid (purity 85%), propionic acid (99%), sodium butyrate (98%), sodium heptanoate (95%), pelargonic acid (99%) and sodium salt of coconut fatty acid distillates (67%), and six EOs: cinnamaldehyde (97--98%), thymol (99%), carvacrol (99%), clove EO (eugenol 80%), oregano EO (phenols 65--75%) and black pepper EO (piperine 40%). Formaldehyde (40%) was also tested as a positive control.

The organic acids sodium butyrate, sodium heptanoate and sodium salt of coconut fatty acid distillates were obtained as powder products and were resuspended in 50 mM sodium phosphate buffer (pH 6.0) depending on their solubility. Final concentrations of these stock solutions were 500,000 ppm (w/v) for sodium butyrate, 50,000 ppm (w/v) for sodium heptanoate and 10,000 ppm (w/v) for the sodium salt of coconut fatty acid distillates. Other organic acids and formaldehyde were provided as liquid preparations and two stock solutions were prepared at 38400 ppm (v/v) for each product in Mueller-Hinton broth (Cultimed, Spain) and brain heart infusion (BHI) (Merck, Germany). Finally, EOs were diluted 1:1 in sterile propylene glycol (Sigma-Aldrich, United States) and then in the same broth media to obtain a final concentration of 38,400 ppm (v/v) as well. All the stock solutions were stored at room temperature.

Antibacterial activity {#Sec5}
----------------------

### Inoculum preparation {#Sec6}

For each tested isolate, three or four fresh bacterial colonies (after 24 to 36 h incubation) were suspended in a NaCl solution (0.85% w/v) to achieve a turbidity between 1 and 2 on the McFarland scale. Before 15 min, these bacterial suspensions were diluted 1:1000 in Mueller-Hinton broth for *E. coli* and *Salmonella* spp. and BHI for *C. perfringens.* Both broth media were previously adjusted to pH 6.0.

### Determination of minimum inhibitory concentration (MIC) {#Sec7}

Susceptibility testing was carried out using the broth microdilution method previously described \[[@CR5]\], in sterile flat bottom 96-well microplates (Jet Biofil, Canada) with a final bacterial concentration of approximately 10^5^ CFU/mL and a volume of 200 μL per well (100 μL of diluted product and 100 μL of bacterial suspension).

Previously, for each assay, the products were diluted in the specific broth media adjusted to pH 6.0 to obtain double the initial concentration tested for each bacterial species. The initial concentration range for each product was determined, taking into account the recommended inclusion rate in feed provided by the supplier. Hence, the inclusion rates in feed recommended in animal production are 1000 ppm for sodium butyrate, 3000 ppm for sodium heptanoate and sodium salt of coconut fatty acid distillates, 250 ppm for the rest of organic acids and 150 ppm for all evaluated EOs. However, if no growth inhibition was detected within the initial range tested, concentrations were increased until inhibition was observed or the maximum possible concentration of the product was reached. The final concentration range evaluated for each product against the three bacterial species is summarised in Table [2](#Tab2){ref-type="table"}. Table 2Final concentration range (ppm) evaluated for each product and bacterial species testedConcentration (ppm)*E. coliSalmonella* spp.*C. perfringens*MaximumMinimumMaximumMinimumMaximumMinimumFormic acid2400.037.52400.037.54800.075.0Propionic acid9600.075.04800.037.54800.075.0Sodium butyrate250,000.0390.6250,000.0390.6250,000.0390.6Sodium heptanoate25,000.0390.625,000.0390.625,000.0390.6Pelargonic acid19,200.0300.038,400.037.54800.075.0Sodium salt of coconut fatty acid distillates5000.078.15000.078.12500.02.0Cinnamaldehyde2400.075.02400.075.02400.075.0Thymol2400.075.02400.075.02400.075.0Carvacrol2400.075.02400.075.02400.075.0Clove EO2400.075.02400.075.02400.075.0Oregano EO2400.075.02400.075.02400.075.0Black pepper EO250,000.075.0250,000.075.0250,000.075.0Formaldehyde4800.04.71200.04.74800.09.4

Incubation was carried out under shaking at 2 x g and 37 °C for 24 h for *E. coli* and *Salmonella* spp. or at 38.5 °C for 24 to 36 h in an anaerobic box (Oxoid, United States) using anaerobic generator sachets (Anaerogen, Oxoid, United States) for *C. perfringens*. All susceptibility tests were performed in triplicate and a maximum difference of one two-fold dilution in MIC values between replicates was allowed.

The MIC was established as the first concentration without visible growth. Data were used to establish the lowest concentration of each product, which inhibited the growth of 50% (MIC~50~) of the strains for each bacterial specie included in the study.

Determination of minimum bactericidal concentration (MBC) {#Sec8}
---------------------------------------------------------

Bactericidal tests were performed as have been previously described \[[@CR5]\], using TSA for *E. coli* and *Salmonella* spp. and FAA for *C. perfringens*. Plates were incubated under optimal conditions for the growth of each bacterial species and the assays were performed in triplicate. The MBC value was defined as the lowest concentration of a product which kills 99.9% or more of the bacteria in the original inoculum (less than 5 colonies). Median (MBC~50~) of the MBC was estimated for each bacterial species.

Determination of fractional inhibitory concentration index (FICI) {#Sec9}
-----------------------------------------------------------------

For each evaluated bacterial species, the four products with lower MIC~50~ (two EOs, one organic acid and positive control formaldehyde) were selected to investigate their interactions in pair-wise combinations. Combined drug antibacterial activity was assessed by means of the FICI and using a modified microdilution checkerboard method as previously described by other authors \[[@CR20]\]. For each bacterial species, a randomly selected strain was employed for this determination (*E. coli* EC 61, *Salmonella* spp. CECT 4300 and *C. perfringens* CP 34). The assays were designed in order to allow the determination of the MIC value of each product alone as well as the combination-derived MIC simultaneously and were carried out in 96-well microplates with a final volume of 200 μL per well. Briefly, within each microplate, the first six rows were used to study the combined effect of the products with six different concentrations being evaluated for each product, including the previously determined specific MIC~50~. Rows G and H include positive and negative control wells and dilutions of each tested product alone for the estimation of the MIC for each single product. Conditions for incubation were the same as previously used for MIC determination and each assay was performed in triplicate.

FICI for each combination was obtained using the following formula: $$\documentclass[12pt]{minimal}
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                \begin{document}$$ FICI= FI{C}_{product\;A}+{\mathrm{FIC}}_{\mathrm{product}\;\mathrm{B},} $$\end{document}$$

where FIC~product\ A~ = MIC~A\ in\ combination~/MIC~A\ alone~ and FIC~product\ B~ = MIC~B\ in\ combination~/MIC~B\ alone~.

Finally, combinations were classified as synergistic (FICI ≤0.5), additive (FICI \> 0.5 and ≤ 1), indifferent (FICI \> 1 and ≤ 4) or antagonistic (FICI \> 4) in accordance with Odds \[[@CR21]\].

Results {#Sec10}
=======

Minimum inhibitory concentration (MIC) {#Sec11}
--------------------------------------

Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"} summarise the MICs for each evaluated product against the three pathogens tested. All tested products, with the only exception of black pepper EO, decreased the growth of at least one of the evaluated strains. In most cases, the differences of MIC values were not greater than one two-fold dilution among the strains of the three bacterial specie, showing intra-species homogeneous susceptibility. Table 3Susceptibility of the strains included to the organic acids tested and formaldehydeStrainMIC (ppm)Formic acidPropionic acidSodium butyrateSodium heptanoatePelargonic acidSodium salt of coconut fatty acid distillatesFormaldehydeEC 60600.02400.062,500.03125.04800.0\> 5000.0150.0EC 61600.01200.062,500.03125.04800.0\> 5000.0150.0EC 67600.02400.062,500.03125.04800.0\> 5000.0150.0EC 961200.01200.050,000.0781.32400.0\> 5000.0150.0EC 107600.01200.050,000.0781.34800.0\> 5000.0150.0EC 115600.01200.050,000.01562.52400.0\> 5000.0150.0SP 11600.01200.0125,000.03125.019,200.0\> 5000.075.0SP 28600.01200.0125,000.0781.34800.0\> 5000.075.0CECT 443600.01200.0125,000.01562.54800.0\> 5000.075.0CECT 700600.01200.0125,000.0781.319,200.0\> 5000.075.0CECT 915600.01200.0125,000.01562.54800.0\> 5000.075.0CECT 4300600.01200.0125,000.01562.54800.0\> 5000.075.0CP 32400.04800.031,250.03125.02400.032.075.0CP 341200.02400.031,250.03125.01200.016.075.0CP 521200.02400.062,500.01562.51200.016.0150.0CP 892400.04800.031,250.01562.52400.016.0150.0CP 991200.02400.031,250.03125.02400.016.075.0CP H2400.04800.031,250.01562.52400.08.0150.0 Table 4Susceptibility of the strains included to the essential oils testedStrainMIC (ppm)CinnamaldehydeThymolCarvacrolClove EOOregano EOBlack pepper EOEC 60600.01200.0300.0600.0600.0\> 250,000.0EC 61300.0600.0300.0300.0300.0\> 250,000.0EC 67600.0600.0600.0600.0600.0\> 250,000.0EC 96600.0600.0150.0600.0300.0\> 250,000.0EC 107600.01200.0600.0600.01200.0\> 250,000.0EC 115600.0600.0300.0300.0300.0\> 250,000.0SP 11600.0600.0300.0600.0600.0\> 250,000.0SP 28300.01200.0600.0600.01200.0\> 250,000.0CECT 443300.0300.0300.0600.0600.0\> 250,000.0CECT 700600.0300.0300.0600.0600.0\> 250,000.0CECT 915600.0300.0300.0600.0600.0\> 250,000.0CECT 4300600.0300.0300.0600.0600.0\> 250,000.0CP 3300.0600.0300.01200.0600.0\> 250,000.0CP 34150.01200.0300.0600.0300.0\> 250,000.0CP 52300.01200.0300.01200.0300.0\> 250,000.0CP 89300.01200.0300.0600.0600.0\> 250,000.0CP 99300.01200.0300.0600.0600.0\> 250,000.0CP H150.01200.0600.0600.0600.0\> 250,000.0 Table 5MIC~50~, MBC~50~ and MBC~50~/MIC~50~ ratio of the organic acids tested and formaldehydeFormic acidPropionic acidSodium butyrateSodium heptanoatePelargonic acidSodium salt of coconut fatty acid distillatesFormaldehyde*E. coli*MIC~50~600.01200.050,000.01562.54800.0\> 5000.0150.0MBC~50~2400.09600.0125,000.01562.519,200.0150.0MBC~50~/MIC~50~4.08.02.51.04.0Not applicable1.0*Salmonella* spp.MIC~50~600.01200.0125,000.01562.54800.0\> 5000.075.0MBC~50~2400.02400.0125,000.01562.519,200.0300.0MBC~50~/MIC~50~4.02.01.01.04.0Not applicable4.0*C. perfringens*MIC~50~1200.02400.031,250.01562.52400.016.075.0MBC~50~2400.02400.062,500.03125.02400.016.0150.0MBC~50~/MIC~50~2.01.02.02.01.0Not applicable2.0 Table 6MIC~50~, MBC~50~ and MBC~50~/MIC~50~ ratio of the EOs testedCinnamaldehydeThymolCarvacrolClove EOOregano EOBlack pepper EO*E. coli*MIC~50~600.0600.0300.0600.0300.0\> 250,000.0MBC~50~1200.01200.0300.0600.0600.0MBC~50~/MIC~50~2.02.01.01.02.0Not applicable*Salmonella* spp.MIC~50~600.0300.0300.0600.0600.0\> 250,000.0MBC~50~2400.0600.0600.01200.0600.0MBC~50~/MIC~50~4.02.02.02.01.0Not applicable*C. perfringens*MIC~50~300.01200.0300.0600.0600.0\> 250,000.0MBC~50~300.01200.0300.01200.0600.0MBC~50~/MIC~50~1.01.01.02.01.0Not applicable

Among organic acids, the best results were obtained with formic acid against *E. coli* and *Salmonella* spp. (MIC~50~ 600 ppm for both bacterial species). Sodium salt of coconut fatty acid distillates inhibited the growth of *C. perfringens* at very low concentrations (MIC~50~ 16 ppm) but showed no activity against Gram negative bacteria (MIC~50~ \> 5000 ppm). Our results revealed a similar susceptibility of all the strains to the tested EOs with black pepper EO being the only exception, with MIC~50~ values ranging between 300 and 1200 ppm. In detail, minimum MIC~50~ (300 ppm) was found for carvacrol and oregano EO against *E. coli*, carvacrol and thymol against *Salmonella* spp. and carvacrol and cinnamaldehyde against *C. perfringens.* Finally, the three bacterial species were susceptible to very low concentrations of formaldehyde with MIC~50~ ranging from between 75 and 150 ppm.

Minimum bactericidal concentration (MBC) {#Sec12}
----------------------------------------

MBC values varied among the three tested bacterial species (Tables [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"}). Sodium salt of coconut fatty acid distillates showed a pronounced bactericidal activity against *C. perfringens* (MBC~50~ 16 ppm). Pelargonic acid also had a higher bactericidal activity against *C. perfringens* (MBC~50~ 2400 ppm) as compared to Gram negative bacteria (MBC~50~ 19,200 ppm).

MBC~50~/MIC~50~ ratio (Tables [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"}) revealed that the highest differences between bacteriostatic and bactericidal concentrations were found among Gram negative bacteria exposed to formic acid, pelargonic acid, propionic acid, cinnamaldehyde or formaldehyde.

Fractional inhibitory concentration index (FICI) {#Sec13}
------------------------------------------------

The lowest FICI values for each combination and strain are listed in Table [7](#Tab7){ref-type="table"}. None of the combinations showed synergism for any of the evaluated bacterial species. Nevertheless, an additive interaction was observed for all the tested combinations, with the only exception being formaldehyde-formic acid and formaldehyde-oregano EO against *E. coli*, with FICI values 1.06 and 1.13, respectively. The combinations with lower FICI values were formaldehyde-carvacrol and carvacrol-oregano EO for *E. coli* (0.63), formic acid-carvacrol and formic acid-thymol for *Salmonella* spp. (0.56) and carvacrol-cinamaldehyde for *C. perfringens* (0.63). Table 7FICI obtained for the combined antimicrobial products*E. coliSalmonella* spp.*C. perfringens*Combination of productsFICICombination of productsFICICombination of productsFICIFormaldehydeFormic acid1.06FormaldehydeFormic acid1.00FormaldehydeSodium salt of coconut fatty acid distillates1.00Carvacrol0.63Carvacrol1.00Carvacrol1.00Oregano EO1.13Thymol0.75Cinnamaldehyde0.75Formic acidCarvacrol0.75Formic acidCarvacrol0.56Sodium salt of coconut fatty acid distillatesCarvacrol1.00Oregano EO1.00Thymol0.56Cinnamaldehyde1.00CarvacrolOregano EO0.63CarvacrolThymol1.00CarvacrolCinnamaldehyde0.63

Discussion {#Sec14}
==========

A number of studies have proposed that organic acids and phytobiotics as the EOs are an interesting alternative to antibiotics use in human and veterinary medicine as well as into carcass decontamination strategies, due to their recognized antibacterial activity \[[@CR4], [@CR5], [@CR9], [@CR22]\]. Controversy about antibacterial activity (i.e. MIC concentration) reported in different studies could be explained by differences in technical aspects of the methods used for the estimation of this activity \[[@CR23]\] and bacterial species or strains included in the studies \[[@CR24]\]. Here, we have focused on the activity of organic acids and EOs against three significant swine enteropathogenic bacteria (*E. coli*, *Salmonella* spp. and *C. perfringens*). The study determines with accuracy the most appropriate products and the potential necessary inclusion rate against each of these three enteric pathogens, providing knowledge for future field research regarding efficacy.

The results of our study confirmed the antibacterial effect of all products tested against the three bacterial species except for black pepper EO. This result is in contrast to previous studies, which have reported activity of this compound against *E. coli* \[[@CR25]\]. The absence of antimicrobial activity of black pepper EO in our study could be a consequence of the low concentration of piperine (40%) since piperine has been proposed as the major active principle in black pepper EO and is responsible for its main properties \[[@CR26]\].

Interestingly, differences in susceptibility of the strains included for each pathogen were scarce, showing a relative low range of MIC. However, the assessment of antimicrobial activity of these products might help to establish the specific dosage for particular strains detected either on farm or at post-harvest. Short-chain organic acids showed higher effect on *Enterobacteriaceae* bacteria, while medium chain organic acids seemed to have higher activity against *C. perfringens*. The outer membrane of Gram-negative bacteria makes the passage of medium size or large molecules more difficult, in contrast to Gram-positive bacteria, which do not possess this membrane. Additionally, protein channels embedded into the lipid bilayer only allow the diffusion into the cytoplasm of Gram-negative bacteria of low molecular weight compounds \[[@CR27], [@CR28]\]. Accordingly, formic acid with the shortest chain length showed the highest antibacterial activity against *E. coli* and *Salmonella* spp. (MIC~50~ 600 ppm for both species) followed by propionic acid. The sodium salt of coconut fatty acid distillates, which main active component is lauric acid, was the most effective against *C. perfringens* (MIC~50~ 16 ppm) but was not capable of inhibiting the growth of *E. coli* and *Salmonella* spp. at the concentrations tested (MIC~50~ \> 5000 ppm). Organic acids could be considered as bioactive compounds when their MIC is equal or lower than 1000 ppm \[[@CR29], [@CR30]\]*.* From our results, only formic acid was shown to be active (MIC 600--1200 ppm) against both *E. coli* and *Salmonella* spp. and the sodium salt of coconut fatty acid for *C****.*** *perfringens*. As demonstrated in this study, current in feed inclusion rates of these products are generally lower than MIC~50~ values. On one hand, these results highlight the relevance of in vitro assays to determine the concentrations at which feed additives exert their antimicrobial effect against enteric pathogens. On the other, compounds such as butyric acid have demonstrated indirect activity, inhibiting the expression of virulence factors required to infect the host \[[@CR31]\], fact that can explain why sub-bacteriostatic concentrations of these compounds can have beneficial effects on the animal health and performance. In addition, results of clinical trial are also influenced by technical aspects and biological factors, which can modify the composition and activity of the products. Bioactivity of all tested EOs was similar between Gram-negative and Gram-positive bacteria as previously described \[[@CR32]\]. With the only exception of thymol against *C. perfringens*, all the EOs evaluated can be considered as antimicrobials since their MIC~50~ values are in the range of 100 to 1000 ppm in accordance with other authors \[[@CR33]\]. In addition, the bioactivity of thymol and oregano EO against *E. coli,* thymol and carvacrol against *Salmonella* spp. and cinnamaldehyde and carvacrol against *C. perfringens* can be classified as moderate (MIC range 126 to 500 ppm), being mild (MIC range 501 to 1000 ppm) for the rest of the EOs \[[@CR29], [@CR30]\].

With regard to bactericidal activity, MBC~50~ values were equal or slightly higher than MIC~50~ values for most of the products tested against the three bacterial species. Similar results have been obtained in previous reports with carvacrol and thymol against the three bacterial species \[[@CR34]\] as well as with eugenol, cinnamaldehyde, thymol and carvacrol against *E. coli* \[[@CR35]\]. The MBC~50~/MIC~50~ ratio in all products that achieved antimicrobial activity was equal or less than 4 and, consequently, these products could be classified as potentially bactericidal agents according to previous proposed cut-off values \[[@CR36]\], with the only exception of propionic acid for *E. coli*. This last product, whose MBC~50~/MIC~50~ ratio was 8, could be considered as a bacteriostatic against *E. coli*.

In agreement with our FICI findings, an additive effect has been reported for several binary combinations of EOs against different bacterial species \[[@CR34], [@CR35], [@CR37]\] or for combinations of EOs and organic acids \[[@CR24]\]. These additive effects would allow the use of binary combinations of products in feed. In this way, a recent research has confirmed the benefits on growth performance of weaned piglets of dietary supplementation with a mixture of organic acids (fumaric acid, citric acid, sorbic acid and malic acid) and EOs (cinnamaldehyde and thymol) \[[@CR38]\].

Conclusions {#Sec15}
===========

The results obtained allow us to conclude that most of the organic acids and EOs evaluated have in vitro bactericidal activity against these three enteric pathogens. Essential oils exhibited a broad spectrum while based on our results we recommend short chain organic acids to control *E. coli* and *Salmonella* spp. and sodium salt of coconut fatty acid for *C. perfringens* infections. The additive effect showed for several combinations of these compounds points at the interest of using combinations of these antimicrobials in infection treatments and strategies to reduce the risk of transmission of these pathogens in meat processing plants.
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